Scheen, André J <br/><br/>
Cardiovascular outcome studies in type 2 diabetes: Comparison between SGLT2 inhibitors and GLP-1 receptor agonists.  [electronic resource] 

 -  Diabetes research and clinical practice  Sep 2018 
 - 88-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1872-8227 
<br/><br/><label>Standard No.: </label>10.1016/j.diabres.2018.06.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Diseases--etiology<br/>Diabetes Mellitus, Type 2--complications<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Sodium-Glucose Transporter 2 Inhibitors<br/>Glucagon-Like Peptide-1 Receptor Agonists